Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
Refoxy Pharma has raised $9.6M in total funding. The most recent round was Seed. The last funding was announced in December 2024.
Refoxy Pharma's investors include HTGF (High-Tech Gruenderfonds), Boehringer Ingelheim Venture Fund, Apollo Health Ventures, Korify Capital, NRW.Venture.
Refoxy Pharma is headquartered in Berlin, Germany.
Developer of therapeutic medicines intended to treat age-related diseases and improve healthy longevity.
Refoxy Pharma is at the Seed stage.
Free to use in articles, research, and reference works. Stable URL — will not change. Data on this page last updated .
"Refoxy Pharma — Funding & Investors." VCBacked, December 4, 2024, https://www.vcbacked.co/company/refoxy-pharma. Accessed August 16, 2026.
VCBacked. (2024). Refoxy Pharma — Funding & Investors. Retrieved August 16, 2026, from https://www.vcbacked.co/company/refoxy-pharma
{{cite web |title=Refoxy Pharma — Funding & Investors |url=https://www.vcbacked.co/company/refoxy-pharma |website=VCBacked |access-date=August 16, 2026}}Profile data sourced and verified per the VCbacked methodology · Last funding round dated